Radiation internal dosimetry in radioimmunotherapy using 131I-rituximab

Radioimmunotherapy (RIT) is a promising approach for targeted therapy to treat intractable cancer because radionuclides are delivered more selective to tumor using monoclonal antibody, RIT can be used clinical practice with administration of murine anti-CD20. In this study, the absorbed dose of total body and red marrow of patient enrolled in RIT study was calculated.